ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 271 filers reported holding ICU MED INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,214,151 | -52.5% | 18,605 | -28.8% | 0.00% | -100.0% |
Q2 2023 | $4,658,911 | +30.2% | 26,146 | +20.6% | 0.00% | 0.0% |
Q1 2023 | $3,577,446 | -26.9% | 21,687 | -30.2% | 0.00% | 0.0% |
Q4 2022 | $4,891,919 | +38.4% | 31,064 | +32.4% | 0.00% | 0.0% |
Q3 2022 | $3,534,000 | -21.1% | 23,466 | -13.9% | 0.00% | 0.0% |
Q2 2022 | $4,481,000 | -40.1% | 27,257 | -18.8% | 0.00% | -50.0% |
Q1 2022 | $7,478,000 | +4.1% | 33,583 | +11.0% | 0.00% | +100.0% |
Q4 2021 | $7,183,000 | -9.6% | 30,260 | -11.1% | 0.00% | -50.0% |
Q3 2021 | $7,946,000 | +37.6% | 34,048 | +21.4% | 0.00% | +100.0% |
Q2 2021 | $5,774,000 | -5.7% | 28,055 | -5.9% | 0.00% | -50.0% |
Q1 2021 | $6,125,000 | +4.6% | 29,816 | +9.3% | 0.00% | 0.0% |
Q4 2020 | $5,853,000 | -34.8% | 27,284 | -44.4% | 0.00% | -33.3% |
Q3 2020 | $8,976,000 | -0.2% | 49,108 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $8,990,000 | -19.0% | 48,778 | -11.3% | 0.00% | -25.0% |
Q1 2020 | $11,094,000 | +10.9% | 54,986 | +2.8% | 0.00% | +33.3% |
Q4 2019 | $10,006,000 | -4.0% | 53,470 | -18.1% | 0.00% | 0.0% |
Q3 2019 | $10,425,000 | -49.2% | 65,317 | -19.9% | 0.00% | -50.0% |
Q2 2019 | $20,537,000 | +0.7% | 81,525 | -4.3% | 0.01% | 0.0% |
Q1 2019 | $20,397,000 | +13.2% | 85,227 | +8.6% | 0.01% | 0.0% |
Q4 2018 | $18,019,000 | -44.0% | 78,469 | -31.0% | 0.01% | -25.0% |
Q3 2018 | $32,149,000 | -48.0% | 113,701 | -46.0% | 0.01% | -52.9% |
Q2 2018 | $61,805,000 | +16.3% | 210,473 | -0.0% | 0.02% | +21.4% |
Q1 2018 | $53,139,000 | -33.0% | 210,536 | -42.7% | 0.01% | -26.3% |
Q4 2017 | $79,313,000 | +11.4% | 367,188 | -4.1% | 0.02% | +11.8% |
Q3 2017 | $71,166,000 | +6.2% | 382,925 | -1.4% | 0.02% | 0.0% |
Q2 2017 | $67,012,000 | +17.3% | 388,473 | +3.8% | 0.02% | +6.2% |
Q1 2017 | $57,141,000 | +21.4% | 374,203 | +17.1% | 0.02% | +23.1% |
Q4 2016 | $47,070,000 | +283.0% | 319,447 | +228.5% | 0.01% | +225.0% |
Q3 2016 | $12,290,000 | +119.9% | 97,245 | +96.2% | 0.00% | +100.0% |
Q2 2016 | $5,588,000 | -51.1% | 49,562 | -54.9% | 0.00% | -50.0% |
Q1 2016 | $11,430,000 | +140.9% | 109,790 | +160.9% | 0.00% | +300.0% |
Q4 2015 | $4,745,000 | -42.0% | 42,074 | -43.7% | 0.00% | -66.7% |
Q3 2015 | $8,184,000 | +1.2% | 74,738 | -11.6% | 0.00% | 0.0% |
Q2 2015 | $8,086,000 | +21.5% | 84,532 | +18.3% | 0.00% | +50.0% |
Q1 2015 | $6,654,000 | -2.3% | 71,441 | -14.1% | 0.00% | 0.0% |
Q4 2014 | $6,811,000 | +146.2% | 83,171 | +93.0% | 0.00% | +100.0% |
Q3 2014 | $2,766,000 | +30.2% | 43,093 | +23.3% | 0.00% | 0.0% |
Q2 2014 | $2,124,000 | +342.5% | 34,941 | +336.1% | 0.00% | – |
Q1 2014 | $480,000 | -93.3% | 8,013 | -92.9% | 0.00% | -100.0% |
Q4 2013 | $7,210,000 | +50.5% | 113,178 | +60.5% | 0.00% | 0.0% |
Q3 2013 | $4,791,000 | +226.1% | 70,533 | +246.1% | 0.00% | +100.0% |
Q2 2013 | $1,469,000 | -23.1% | 20,382 | -35.0% | 0.00% | 0.0% |
Q4 2012 | $1,911,000 | -2.3% | 31,362 | -3.0% | 0.00% | 0.0% |
Q3 2012 | $1,956,000 | +84.0% | 32,338 | +62.4% | 0.00% | – |
Q2 2012 | $1,063,000 | +61.8% | 19,907 | +49.1% | 0.00% | – |
Q1 2012 | $657,000 | – | 13,354 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |